4//SEC Filing
Furiex Pharmaceuticals, Inc. 4
Accession 0001181431-10-034127
CIK 0001484478operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:43 PM ET
Size
6.5 KB
Accession
0001181431-10-034127
Insider Transaction Report
Form 4
COVINGTON PAUL S
Senior VP-Clinical Operations
Transactions
- Award
Stock Options (to buy)
2010-06-17+75,691→ 75,691 totalExercise: $9.11Exp: 2020-06-17→ Common Stock (75,691 underlying)
Holdings
- 73
Common Stock
Footnotes (2)
- [F1]Represents shares acquired in a pro rata distribution by PPDI.
- [F2]The options were awarded on 06/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided that the Optionee's employment continues.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001484478
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:43 PM ET
- Size
- 6.5 KB